Beranda › Kanker Paru Non-Sel Kecil › New Jersey › Camden
Uji klinis Kanker Paru Non-Sel Kecil di Camden, NJ
11 studi untuk Kanker Paru Non-Sel Kecil mencari peserta di lokasi sekitar Camden (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Menerima pesertaFase 3
- Jefferson Health - Cherry Hill, Cherry Hill · 5 mi jauhnya
- Sidney Kimmel Cancer Center - Washington Township, Sewell · 11 mi jauhnya
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Menerima pesertaFase 3
- Research Site, Camden
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Menerima pesertaFase 3
- Clinical Study Site, Mullica Hill · 14 mi jauhnya
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Menerima pesertaFase 1/2
- MD Anderson Cancer Center at Cooper- Two Cooper Plaza, Camden
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Menerima pesertaFase 2
- MD Anderson Cooper, Camden
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
Menerima pesertaFase 2
- Inspira Medical Center Mullica Hill, Mullica Hill · 14 mi jauhnya
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Menerima pesertaFase 2
- Virtua Samson Cancer Center, Moorestown · 10 mi jauhnya
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Menerima pesertaFase 2
- Virtua Samson Cancer Center, Moorestown · 10 mi jauhnya
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Menerima pesertaFase 2/3
- Virtua Samson Cancer Center, Moorestown · 10 mi jauhnya
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Menerima pesertaFase 2
- Virtua Samson Cancer Center, Moorestown · 10 mi jauhnya
Incentive Spirometry to Improve Outcomes in Lung Cancer Patients Undergoing Concurrent Chemotherapy and Radiation Therapy
Menerima peserta
- MD Anderson Cancer Center at Cooper, Camden
Uji klinis Kanker Paru Non-Sel Kecil di kota lain
- Houston, TX145 studi
- New York City, NY121 studi
- Arlington, VA104 studi
- Nashville, TN97 studi
- Boston, MA90 studi
- Los Angeles, CA87 studi
- St. Louis, MO73 studi
- Chicago, IL61 studi
- Baltimore, MD60 studi
- San Antonio, TX59 studi
- Columbus, OH57 studi
- Washington, DC55 studi
Studi lain di Camden
- Skizofrenia10 studi
- Kanker Paru9 studi
- Gagal Jantung8 studi
- Kanker Payudara8 studi
- Gangguan Depresi Mayor6 studi
- Kanker Ovarium6 studi
- Penyakit Kardiovaskular6 studi
- Penyakit Arteri Koroner6 studi
- Tekanan Darah Tinggi5 studi
- PPOK5 studi
- Kanker Endometrium5 studi
- Kanker (semua jenis)5 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.